NCT05994092

Brief Summary

All the study participants performed the Wingate Anaerobic Test (WAnT) with maximal effort. The experimental group (E) performed a 3-minute recovery protocol based on low-intensity breathing Voluntary Isocapnic Hyperpnea exercises 20 minuter after cessation of the exercise, whereas the control group (C) used passive recovery only. All study participants were advised to sit during the 30-minute period, with minimal walking in order to meet the physiological needs allowed. The blood samples were taken 3 minutes and 30 minutes after cessation of the exercise to measure the bLa. The Borg CR-10 Scale was presented to the participants 3 minutes and 30 minutes after cessation of the exercise to measure the rate of perceived exertion (RPE) (Borg, 1998).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 10, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2023

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

August 8, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 16, 2023

Completed
Last Updated

August 18, 2023

Status Verified

August 1, 2023

Enrollment Period

2 months

First QC Date

August 8, 2023

Last Update Submit

August 15, 2023

Conditions

Keywords

Voluntary Isocapnic HyperpneaLactate Clearance

Outcome Measures

Primary Outcomes (2)

  • Changes in blood lactate (bLa)

    The blood samples were taken 3 minutes and 30 minutes after cessation of the exercise to measure the bLa. Blood samples were taken from fingertips by skilled technicians to 20 uL capillary tubes. bLa was measured with Super GL2 analyzer (Dr. Müller Gerätebau GmbH, Freital, Germany).

    30 minutes

  • Changes in rate of perceived exertion (RPE)

    The Borg CR-10 Scale was presented to the participants 3 minutes and 30 minutes after cessation of the exercise to measure the rate of perceived exertion (RPE) (Borg, 1998).

    30 minutes

Study Arms (2)

Experimental

EXPERIMENTAL
Behavioral: Voluntary Isocapnic Hyperpnea

Control

NO INTERVENTION

Interventions

The protocol of 3' of breathing with 20 breaths·min-1 frequency. The Isocapnic BreathWayBetter devices (Isocapnic Technologies Inc, Kelowna, Canada) with 6-liter bags were used. The protocol was performed in a seating position.

Experimental

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • valid medical certificate to compete in speedskating,
  • lack of previous experience with RMT,
  • at least 6 years of athletic training.

You may not qualify if:

  • any chronic medical condition,
  • any acute medical condition within last 3 months,
  • any ongoing medication intake.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Sport - National Research Institute

Warsaw, 01-982, Poland

Location

Related Publications (1)

  • Kowalski T, Wilk A, Rebis K, Lohse KM, Sadowska D, Klusiewicz A. Influence of voluntary isocapnic hyperpnoea on recovery after high-intensity exercise in elite short-track speedskaters - randomized controlled trial. BMC Sports Sci Med Rehabil. 2024 Jun 20;16(1):137. doi: 10.1186/s13102-024-00927-0.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Parallel Group Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 8, 2023

First Posted

August 16, 2023

Study Start

June 10, 2023

Primary Completion

July 30, 2023

Study Completion

July 30, 2023

Last Updated

August 18, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will share

Upon reasonable request.

Locations